Temedica is a tech-, AI-, and data-enabled solution and service provider for the pharmaceutical industry. They empower pharma companies to achieve exceptional brand performance with a holistic strategy and tactical execution. By combining real-world insights, configurable AI-powered solutions, and deep medical expertise, they turn the biggest challenges in pharma commercialization into tangible success.

Temedica believes that personalized patient treatment is a fundamental right of every patient and is key to better overall care quality. They improve patient outcomes by generating new insights across various indications. Their approach challenges the traditional one-size-fits-all treatment model by focusing on the individual at the center of care.

Temedica is guided by principles such as aiming high, ownership, making real impact for customers, and winning together through a diversified and collaborative team.

They offer AI-powered real-world insights through products like Permea Monitor, digital guides to boost patient activation and adherence with Patient Companion, and expert services tackling commercial and medical roadblocks. Their solutions include market insights and analysis, competitive benchmarking, launch excellence, brand strategy and management, stakeholder engagement, patient journey analysis, retention and adherence solutions, real-world evidence generation, medical communication, and omnichannel patient marketing.